Want to join the conversation?
$BIIB and Swedish Orphan Biovitrum said they will present updated data on long-term safety and efficacy of the companies' novel extended half-life therapies, ELOCTATE for hemophilia A and ALPROLIX for hemophilia B. Hemophilia is a rare, genetic disorder in which the ability of a person's blood to clot is impaired.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.